Your session is about to expire
← Back to Search
Radiotherapy Response Monitoring for Head and Neck Cancers
N/A
Recruiting
Led By Gregory J Czarnota, PhD, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Summary
In this study, PA imaging will be used to examine the physiological and physical changes in lymph node involvements of head and neck cancer during radiotherapy with or without chemotherapy. Our objective in this pilot study will be to evaluate if PA parameters change within the lymph node involvements during chemoradiation therapy over time. Our hope is to use this information to correlate the changes in measured PA parameters with radiological response.
Eligible Conditions
- Head and Neck Cancers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation of response to treatment between photoacoustic parameters and final radiological outcome. measures of outcome.
Secondary outcome measures
Correlation between photoacoustic parameters and five-year overall survival.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Radiotherapy Response MonitoringExperimental Treatment1 Intervention
Those undergoing radiation therapy treatment to their lymph nodes upon diagnosis of head and neck cancer
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
671 Previous Clinical Trials
1,564,585 Total Patients Enrolled
Gregory J Czarnota, PhD, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
6 Previous Clinical Trials
1,960 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger